I hate companies that report between 25 Feb and 28 Feb and even worse 1 March. Really if you care about shareholders you should be able to get in before 1 month and 25 days that's not that hard.
Having said that I think that there is nothing wrong - just a share that doesn't as yet have the audience it needs. I am not sure how the mix stacks up with Interprac etc.
These results are going to be a bit of a mixing bowl I think - no clarity yet lots of promise - hopefully, management can unpack it for us.
SEQ Price at posting:
30.0¢ Sentiment: None Disclosure: Held
